American College of Clinical Pharmacy
      Search      Cart
         

SCHEDULE

BCCCP Clinical Session — The Big Squeeze: Mastering Rescue Therapies for Vasoplegia

Monday, October 19, 2026 from 12:30 p.m. to 1:30 p.m. MDT at Salt Palace Convention Center - Ballroom E

  This session is being recorded.   Learn More

Available for 1.00 hours of CPE credit
Activity Number: 0204-9999-26-300-L01-P
Activity Type: An Application-Based Activity

This session provides a comprehensive update on the pathophysiology and management of vasoplegia, specifically targeting pharmacists who practice in the operating room and ICU. This session will address critical knowledge gaps regarding selection and management of non-traditional agents in this setting. Earlier identification and proactive use of these agents will assist attendees in successfully managing patients through an algorithmic approach.

This activity is approved for Board Certified Critical Care Pharmacist (BCCCP) recertification credit.

The BCCCP Clinical Sessions are part of the professional development program for the recertification of board-certified Critical Care pharmacists by the Board of Pharmacy Specialties and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP). In order to earn the BCCCP recertification credit, participants must attend the session, claim the continuing pharmacy education credit, and pass the associated posttest.  Access to the Clinical Sessions posttests will be available on December 16, 2026, at www.accp.com/myaccount to anyone who has purchased access to the BCCCP posttests. For participants who have not purchased access to the posttests, access can be purchased until 12:00 p.m. on Tuesday, October 20, at the ACCP Registration Desk. The deadline to submit posttests for these sessions will be December 14, 2027.  

Learning Objectives

1. Define hemodynamic criteria for vasoplegia and explain key pathophysiologic pathways involved in its development.

2. Assess key risk factors to stratify patients at high risk for refractory shock.

3. Evaluate literature related to vasoplegia treatment options supporting the efficacy and safety of emerging therapies.

4. Construct a vasoplegia treatment algorithm accounting for patient and drug-specific factors.

Nicholas Barker, Pharm.D., BCCCP, BCCP
Speaker:Nicholas Barker, Pharm.D., BCCCP, BCCP

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.